Published in Hospital Business Week, June 22nd, 2008
The NCCN Compendium will be used by CMS for national coverage determinations and by intermediaries and carriers for locoregional determinations. The major application will be in determinations about coverage for the use of drugs and biologics in oncology beyond the FDA approved indication.
This recognition comes on the heels of a recent announcement that UnitedHealthcare...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week